New Report: Substance-K Receptor - Pipeline Review, H1 2016

From: Fast Market Research, Inc.
Published: Sun Jun 19 2016


Global Markets Direct's, 'Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) - Pipeline Review, H1 2016', provides in depth analysis on Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) targeted pipeline therapeutics.

The report provides comprehensive information on the Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) targeted therapeutics development and features dormant and discontinued projects.

Full Report Details at
- http://www.fastmr.com/prod/1185709_substance_receptor_skr_or_nk.aspx?afid=301

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Report Scope

* The report provides a snapshot of the global therapeutic landscape for Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2)
* The report reviews Substance-K Receptor (SKR or NK-2 Receptor or Neurokinin A Receptor or Tachykinin Receptor 2 or TACR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
* The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- N-Formyl Peptide Receptor 2 (FMLP-Related Receptor I or FMLP-R-I or Formyl Peptide Receptor-Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2016
- Proteinase-Activated Receptor 2 (Coagulation Factor II Receptor-Like 1 or G-Protein Coupled Receptor 11 or Thrombin Receptor-Like 1 or F2RL1 or GPR11) - Pipeline Review, H1 2016
- Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor 2 or MC2R or ACTHR) - Pipeline Review, H1 2016
- Nuclear Receptor ROR-Gamma (Nuclear Receptor RZR-Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR-Related Orphan Receptor C or Retinoid-Related Orphan Receptor-Gamma or RORC) - Pipeline Review, H1 2016
- Peroxisome Proliferator-Activated Receptor Delta (PPAR-Delta or NUCI or Nuclear Hormone Receptor 1 or NUC1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator-Activated Receptor Beta or PPAR-Beta or PPARD or NR1C2) - Pipeline Revie

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »